HEALTHCARE
“ The Company is creating novel and personal ways for patients and their families to connect , virtually and live , with each other , UCB , their
partners and opinion formers .”
and immunology diseases to provide new treatments for specialists and their patients .
Key features Patients are at the heart of all that UCB Australia does , driving their commitment to the treatment of severe diseases . In addition , the Company ’ s international R & D organisation comprised of UCB NewMedicines and UCB Global Projects and Development gives UCB comprehensive strength and resources . And UCB ’ s track record of successful partnerships with both academia and leading drug discovery organizations showcases how partnerships are very much a central component of the Company ’ s philosophy .
One Team Approach UCB ’ s philosophy is to have a ‘ one team ’ approach to drug discovery and development with seamless integration of research , development and commercial colleagues , in a process of continual learning and confirming as they examine their data and capitalise on their knowledge .
Company Information
INDUSTRY
Healthcare
HEADQUARTERS
Malvern Victoria , Australia
FOUNDED
1920 ’ s
EMPLOYEES
40
REVENUE
$ 60 Million
PRODUCTS / SERVICES
UCB Australia combines biology and chemistry to make major breakthroughs . By integrating their expertise in large , antibody-based molecules and small , chemicallyderived molecules , they can offer families with severe diseases and their specialist physicians the advantages of both large and small molecules to produce extraordinary breakthroughs .
www . ucb . com / 105